India
Launch of generic oncology drugs underway in India
The government has approved generic versions of a kidney cancer drug.
Launch of generic oncology drugs underway in India
The government has approved generic versions of a kidney cancer drug.
Fortis Memorial Research Institute launches pediatric tumor clinic
The clinic aims to treat children with a variety of solid tumors and cancers.
Private sector growth boosts India's medical devices market
The country could rely more on the sector due to rising healthcare expectations.
Indian telehealth startup MFine bags $16m in funding round
The funds will be partly used towards tripling its investment in AI.
India needs to invest in resilient healthcare information infrastructure: report
Risk communication emerged as the weakest link during the pandemic.
Are India's underfunded hospitals equipped to deal with the pandemic?
The country is unable to raise healthcare expenditure by more than 3.8% of GDP, compared to the APAC average of 6.64%.
India medicine sales to increase 9.4% by 2029
Telemedicine service is expected to prevail in the coming years.
India's worst-hit state creates stir over sourcing of COVID-19 drug
The government and private sector were urged to collaborate on its pricing.
New potential COVID-19 drug a boon for India's pharmas
It could help address issues such as shortage of ventilators.
India slated to lead in pharma exports: analyst
Forecast shows India’s pharmaceutical export value will rise to US$30.8b by 2024.
India urged to ramp up healthcare spending
The country ranked at 170 out of 188 countries in health expenditure.
India's hospitals reel from outpatient slump
People have been reluctant to visit hospitals out of fear of the pandemic.
Lack of funding, infrastructure looms over India's healthcare sector
The country only has 8 physicians per 10,000 population.
India bans exports of alleged coronavirus drug
It will be limited to fulfilling existing contracts and humanitarian grounds.
India's API imports fell 4.9% YoY in 7M FY 2020
This followed two years of increasing import dependency for API.
India greenlights 50% price hike for 21 drug formulations
Many drug manufacturers were on the brink of product discontinuation due to rising operating costs.
India eyes single regulatory framework for local and foreign medical devices
All imported devices are currently subject to US FDA approval for registration.
Most Read
1. Western Health takes home Healthcare Asia Awards 2024 for EMR system expansion 2. Global Doctors Hospital innovates holistic healthcare through wellness programmes 3. MSD navigates the pandemic tapestry in COVID-19 fight 4. ZP Therapeutics bagged Healthcare Asia Pharma Awards 2024 for continuing medical education 5. Japan's insulin pen market sees 3% CAGR growthResource Center
Read Here
Advertise
Sign Up
Event News
Event News
MSD navigates the pandemic tapestry in COVID-19 fight
![MSD navigates the pandemic tapestry in COVID-19 fight]()
Co-Written / Partner
It has navigated the complexities of the challenging period through a proactive approach.
It has navigated the complexities of the challenging period through a proactive approach.
